Anne Angelillo-Scherrer Selected Research

Anne Angelillo-Scherrer Research Topics

Disease

16	Hemorrhage 09/2023 - 09/2010
10	Thrombosis (Thrombus) 01/2023 - 02/2005
7	Neoplasms (Cancer) 11/2023 - 01/2014
7	Venous Thromboembolism 09/2023 - 01/2015
6	Thrombocytopenia (Thrombopenia) 09/2022 - 09/2009
5	Hemophilia A (Haemophilia) 03/2021 - 05/2013
4	COVID-19 01/2023 - 11/2021
4	Anemia 01/2018 - 02/2008
3	Pulmonary Embolism 09/2019 - 01/2014
2	Thrombophilia 01/2023 - 07/2022
2	Inflammation (Inflammations) 01/2023 - 01/2022
2	Infections 01/2022 - 11/2004
2	Autoimmune Diseases (Autoimmune Disease) 11/2021 - 10/2020
2	Liver Diseases (Liver Disease) 09/2021 - 12/2018
2	Diabetes Mellitus 01/2017 - 01/2015
2	Thromboembolism 09/2009 - 05/2006
2	Atherosclerosis 02/2009 - 08/2002
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023
1	Hyperhomocysteinemia 01/2023
1	Pneumonia (Pneumonitis) 09/2022
1	Hemoglobinopathies 04/2022
1	Virus Diseases (Viral Diseases) 04/2022
1	Hemolysis 04/2022
1	Peritonitis 01/2022
1	Endotoxemia 01/2022
1	Eosinophilia 01/2021
1	Metrorrhagia (Spotting) 12/2020
1	Disease Susceptibility (Diathesis) 10/2020
1	Plasma Cell Neoplasms 10/2020
1	Pathologic Complete Response 10/2020
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2019

Drug/Important Bio-Agent (IBA)

8	AnticoagulantsIBA 01/2023 - 11/2012
7	Thrombin FDA Link 09/2023 - 09/2009
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2004
4	Heparin (Liquaemin)FDA LinkGeneric 09/2022 - 12/2014
3	Fibrinogen (Factor I)FDA Link 01/2023 - 12/2017
3	Factor VIII (Coagulation Factor VIII)IBA 12/2020 - 05/2013
3	FibrinIBA 01/2020 - 09/2009
3	Thromboplastin (Tissue Factor)IBA 12/2018 - 09/2009
2	Phosphotransferases (Kinase)IBA 11/2023 - 05/2006
2	ThrombomodulinIBA 09/2023 - 09/2021
2	InflammasomesIBA 01/2023 - 01/2022
2	fibrin fragment D (D-dimer)IBA 01/2023 - 01/2017
2	Platelet Factor 4IBA 09/2022 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 04/2022 - 01/2018
2	Hemostatics (Antihemorrhagics)IBA 09/2021 - 01/2019
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2020 - 01/2018
2	Protein CIBA 01/2020 - 09/2009
2	Protein SIBA 01/2020 - 01/2018
2	Factor XII (Hageman Factor)IBA 01/2020 - 01/2017
2	C-Reactive ProteinIBA 09/2019 - 01/2017
2	Prothrombin (Factor II)IBA 10/2017 - 11/2009
2	Vitamin K FDA Link 01/2015 - 08/2011
1	trametinibIBA 11/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2023
1	Deoxyribonucleases (DNase)FDA Link 11/2023
1	Factor Xa InhibitorsIBA 01/2023
1	prothrombin complex concentrates (PPSB)IBA 01/2023
1	apixabanIBA 01/2023
1	edoxabanIBA 01/2023
1	PRT064445IBA 01/2023
1	RivaroxabanIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Deoxyribonuclease I (Nickase)IBA 01/2023
1	HomocysteineIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	AntibodiesIBA 09/2022
1	hemoglobin MontrealIBA 04/2022
1	Uric Acid (Urate)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Rituximab (Mabthera)FDA Link 11/2021
1	Messenger RNA (mRNA)IBA 11/2021
1	ocrelizumabIBA 11/2021
1	InterferonsIBA 11/2021
1	VaccinesIBA 11/2021
1	Interleukin-5 (Interleukin 5)IBA 01/2021
1	emicizumabIBA 12/2020
1	Prednisolone (Predate)FDA LinkGeneric 10/2020
1	Lenalidomide (CC 5013)FDA Link 10/2020
1	Bortezomib (Velcade)FDA Link 10/2020
1	Thalidomide (Thalomid)FDA Link 10/2020
1	Immunomodulating AgentsIBA 10/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020
1	AutoantibodiesIBA 10/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2020
1	Cyclic PeptidesIBA 01/2020
1	Factor X (Stuart Factor)IBA 01/2020
1	ferric chlorideIBA 01/2020
1	SolutionsIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 10/2019
1	pro-brain natriuretic peptide (1-76)IBA 09/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2019
1	Troponin T (Troponin T1)IBA 09/2019

Therapy/Procedure

11	Therapeutics 01/2023 - 02/2005
2	Extracorporeal Membrane Oxygenation 09/2022 - 01/2020
2	Polypharmacy 01/2017 - 01/2015
1	Anticoagulation Reversal 01/2023
1	Transplantation 11/2021
1	Autologous Transplantation 10/2019